B Cells and Diseases Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define PIDs.

A

Primary Immunodeficiencies are disorders characterised by an impaired ability to produce a normal immune response that typically result in recurrent or severe infections. It is not caused by other diseases, treatments, or exposure to toxins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Recall some examples of PID.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we usually treat PIDs?

A
  • Usually by replacing the whole immune system if it’s completely missing (e.g. most severe forms, SCID, X-linked agmmaglobulinaemia)
    • Gene therapy
    • Haematopoietic stem cell transplantation (HSCT)
  • Usually not the best option for patients with some form of immunity but increasing considered
  • Replace antibodies through intravenous Ig (IVIg) or sub-cutaneous Ig (SCIg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

All lymphocytes descend from a ______________. Mention where the lymphocytes develop.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

B cells develop in the ___________. Then, they exit through the ____________ to the periphery where thwy differentiate.

A

Bone marrow, sinusoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

B cells are precursors to ____________.

A

Plasma cells (antibody-secreting cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

To make antibodies, a B cell must:

A
  1. Recognize antigen via immunoglobulin on the surface
    • Surface membrane Immunoglobulin = B cell receptor
  2. Break down Ag and re-present to T-cells as peptides on surface MHC class II
  3. T cells then provide activation signals or ‘help’ (CD40L, ICOS, cytokines)
  4. Allow B-cell to differentiate to antibody-secreting cells (ASCs) and memory B cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Recall what B cells do.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is an antibody?

A

It is produced by plasma cells. They are globular proteins found in serum, interstitial fluids, and mucosal secretions. Their function is to identify and neutralise foreign pathogens (mark them for degradation). Each antibody binds to a specific antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the structure of antibodies.

A

They are made up of 4 chains: 2 identical Heavy (H), 2 identical Light (L) chains. It has two regions: variable and constant regions.

L+ H chains are paired by disulphide bond in each dimer. H + H paired by disulphide bonds in each tetramer. Heavy chains give ‘Y’ structure of Ab.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the constant and variable regions of the antibodies.

A

The variable region serves as the ‘antigen-binding site’. It is extremely variable.

The constant region dictates the class/isotype of antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Recall the schematic representations of the antibodies’ classes.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Recall B cell activation and differentiation in reverse.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Briefly explain how B cells are clonally selected.

A
  1. A specific BCR recognizes the specific antigen
  2. The corresponding B-cell is ‘selected’ by the antigen
  3. They are then stimulated (clonal expansion) and differentiated (Ab secretion).

Note:

  • B cells are quiescent unless stimulated to respond
  • B cells usually need instructions from CD4 T cells to proliferate and differentiate
  • B cell response to antigen changes with time (affinity and effector functions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Both B and T cells undergo _________________ to remove cells that bind with high self affinity.

A

Negative Selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the mechanism of production of a diverse range of antibodies.

A

The immunoglobulin gene locus encodes for multiple genes for the variable and constant regions of both chains. There are three separate genes on 3 loci.

The variable region of the H chains is encoded by 3 separate segments (V, D, J), while for the L chain it is encoded by 2 segments (V, J). Each variable domain is a result of the recombination of the option from each segment.

Ig diversity comes partly from having:

  • Random selection and rearrangement of VDJ (heavy) and VJ (light) genes at each locus;
  • Independent rearrangement at Heavy and at Light chain loci; the pairing of various combinations
    • 2 light chain genes (κ and λ) to choose from
  • Imprecision of junctions (N region diversification, random insertion of nucleotides at junction regions, mediated by TdT)
  • Somatic Hypermutation and Affinity Maturation: single point mutations in hypervariable regions and selection of highest binding receptors.
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Recall the Ig Gene rearrangement and B cell maturation sequence.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the RSS?

A

Recombination Signal Sequence is a unique nucleotide sequence that is the RAG recognition sequence, is adjacent to each mini-gene segment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is RAG1/2?

A

Recombination Activating Genes are essential to Ig gene recombinati0on, they provide the recognition and DNA cleavage activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is HMG1?

A

High Mobility Group 1 protein is a chromatin-binding, structural protein also required for rearrangement but not uniques to Ig gene rearrangement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the Artemis/DNA-Protein Kinase catalytic subunit (DNA-PKcs)/Ku70,80 complex function?

A

It is involved in the recognition and synapsis of DNA ends.

Autophosphorylation of DNA-PKs activates Artemis, which is a nucelase that opens the coding end of the haripins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the DNA Ligase IV/XRCC4?

A

The complex is responsible for joining the DNA ends.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the TdT?

A

Terminal deoxynucleotidyl transferase is unique to B cells and adds extra random nucleotides to the broken ends at V-D-J junctions (doesn’t work at L chain loci).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mention the three steps of VDJ recombination.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the structure of the RSS.

A

RSS has 3 elements:

  • heptamer of 7 conserved nucleotides,
  • spacer of 12/23 basepairs, and
  • nonamer of 9 conserved nucleotides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe the 1st step in VDJ recombination.

A

Step 1 involves the selection of V and J regions to recombine.

RSS are recognised by RAG1 and RAG2, which are proteins that cut DNA at randomly selected RSS, making double-stranded DNA breaks. RAG1 and RAG2 forms a complex with HGM1.

The cut ends are then ligated to form:

  • Coding joint (hairpins)
    • V-J, then V-DJ for H chains
    • V-J for L chains
  • Signal end joints: loop of DNA deleting al intervening DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe the 2nd step of VDJ recombination.

A

It involves the non-homologous end joining (NHEJ).

DNA-protein kinases (DNA-PKcs) bind to each broken DNA ends and recruits Artemis, Ku70 & Ku80 to forms a complex. This complex then recognise and closes the DNA ends.

Autophosphorylation of DNA-PKcs activates Artemis, which opens the coding-end hairpins (essential for NHEJ DNA repair).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe the 3rd step of VDJ recombination.

A

It involves the DNA ends ligating together.

DNA-PKcs & XRCC4 (DNA Ligase) align DNA ends and recruit the TdT enzyme. TdT is a DNA polymerase that adds random nucleotide to coding-end in 5’ to 3’ direction. Exonucleases remove bases from coding ends and DNA polymerases fill in nucleotides compatible for joining. Processed coding ends ligated together by Ligase IV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Immature B cells only able to leave BM if express ____________ on surface.

A

functional Ig (called BCR)

30
Q

Describe the features of SCID.

A
31
Q

Describe how can a newborn be screened for PID.

A

Signal Joint is a circular DNA segment that is a byproduct of a successful VDJ rearrangement in a B cell/T cell. It is called KRECS in B cells, TRECS in T cells. These circular DNA persist in cells and dilute with cell division as markers of new B cell output. Quantification of TRECs and KRECs by simple quantitative PCR would allow early detection of suspected PID. Absence of TRECS/KRECS indicate possible absence of T/B cells/

32
Q

How is SCID diagnosed?

A
  • Complete blood counts: often low lymphocyte counts
  • Lymphocyte counts: T cells always absent/dysfunctional; B and NK cells may be absent depending on type
  • Serum Ig levels: No or very little serum immunoglobulin of any isotope (no T cell help)
  • Specific genetic testing
  • Newborn screening (NBS)
33
Q

Describe the management and treatment of SCID.

A
  • Management:
    • Medication: antibiotics, antifungals to treat/prevent infections
    • Avoiding exposure to infections
    • Immunoglobulin supplementation (IVIG or SCIg)
  • Treatment:
    • Enzyme replacement therapy: PEG-ADA for patients with ADA deficiency
    • Haematopoietic Stem cell transplantation (HSCT): most effective and only curative option
    • Gene therapy: X-SCID (IL2RG) and ADA-SCID (ADA)
34
Q

Explain how does the cell know when the Ig VH gene rearrangement is successful.

A

After the VDJ recombination and the formation of the H chain, the H chain pairs with two Surrogate Light Chains (SLC). SLC are them same in every B cell - not generated by rearrangement, which acts as a generic scaffolding as the real L chain are not yet arranged.

The IgH-SLC complex pairs with the signalling chains Igα and Igß to form the pre-BCR, which then sens the ‘success’ signal into the cell.

35
Q

What marks the completion of the first stage of B cell development?

A

After the VJ recombination of the L chain, they paired with the existing H chain to form the complete Ig on the surface. IgHL complex pairs with Igα and Igß to form the BCR which sends another ‘success’ signal into the cell. This marks the end of the Ig gene rearrangement.

36
Q

Mutation in BTK gene causes __________________. Describe the molecular cause of it.

A

X-linked agammaglobulinaemia (XLA):

  • a kinase that is involved in the signalling pathway that signals rearrangement success
  • mutation occur along the entire gene with no single mutation occurring >3%
  • some result in residual Btk expression and signalling (variable phenotype)
  • Mutation maintained in the population by de novo events
  • BTK gene encoded on X-chromosome; thus almost exclusively affects males
37
Q

Describe the symptoms of XLA.

A
  • Complete absence/very little serum Ig (all isotypes)
  • complete absence circulating B cells, normal T cells
  • Recurrent infections
  • Recurrent otitis in children and sinusitis in adults
    • Usually well-protected against viruses
  • Average age of diagnosis 3 years old
    • due to mater Ig protection on early months after birth
38
Q

How do you diagnosis XLA?

A
  • Clinical presentation + family history
    • measure serum Ig (if > 1 year)
    • enumerate CD19* B cells
    • BTK sequencing
  • Genomic testing: prenatal (chorionic villus sampling, amniocentesis), KRECs newborn screening
39
Q

Mention the treatments for XLA.

A
  • Intravenous Ig - Intragam 10
    • Purified IgG from pooled human sera using alcohol fractionation
    • contains all subclasses and traces of IgM and IgA
    • Dose is 400-600 mg/kg per month in clinic
    • takes 2-4 hours per infusion
    • 80% of patients have >1 major infectious complication afterwards
  • Subcutaneous immunoglobulin (SCIg)
    • self-administered weekly in abdomen, thigh and forearms - via a small pump
      • more freedom to travel and work
    • dose is 100-150 mg/kg
    • No observed adverse reactions
    • Avoids peaks/throughs of IVIG; fewer infections in between treatment
40
Q

Ig V region rearrangement occurs in the _____________.

A

Bone marrow

41
Q

Immature B cells, that express a functional surface Ig (BCR) leave __________ via blood and migrate to the __________.

A

bone marrow, spleen

42
Q

Describe the primary immune response to a protein antigen.

A

Initial exposure to antigen mostly induces IgM secretion (low affinity, high avidity) followed by some IgG or IgA (higher affinity). Change in isotype or class of Ig typically occurs (class switch recombination). Antigen specificity remains unchanged. CSR from IgM to IgG1, or IgA1, or IgE is not random, but directed by signals from T cells and/or antigen.

43
Q

Define affinity and afidity.

A

Affinity: binding strength between epitope and Ag binding site

Avidity: overall strength Ab-Ag complex (ie. functional affinity)

44
Q

Describe the memory response to a protein antigen.

A
  • Secondary response
    • faster kinetics
      • mount a first IgM response, but rapidly produces IgG
    • greater magnitude (more antibody) than the primary response
    • not usually associated with further CSR, but maybe
    • higher affinity than primary Ab (tighter binding of the antibody to antigen; through Somatic Hypermutation)
45
Q

Describe the early stages of B and T cell activation.

A
46
Q

Class switching mostly occur before SMH in the ____________ of the lymph node.

A

follicle

47
Q

Recall the following regarding variable and constant Ig region.

A
48
Q

Define isotype switching.

A

Also known as class switch recombination - changing the constant region of the antibody heavy chain without changing the V regions and thus the specificity. It also changes the effector function of the Ab.

49
Q

Define somatic hypermutation.

A

It refers to the random introduction of point mutations into the V gene segments of the H and L chains to diversify binding to the antigen. This happens during B cell proliferation and occurs in the dark zone of GC.

50
Q

Describe the process of affinity maturation in the GC.

A

It refers to activated B cells producing antibodies with increased affinity for antigen during the course of an immune response. A secondary response can elicit antibodies with several-fold greater affinity than in a primary response.

Affinity maturation primarily occurs on surface immunoglobulin of the germinal centre of B cells and as a direct result of somatic hypermutation (introduced by the AID) and selection by Tfh cells (higher affinity => drive proliferation).

51
Q

Describe the process of CSR.

A

Naive B cells express IgM and IgD on their surface, with the transcription of the H chain genes starting from the promotor upstream of the VH segment. Thus, exons encoding the constant regions can’t be expressed until the variable segment is placed upstream of them.

Switch (S) regions are upstream of each C region. Only on activated B cell, AID enzyme is expressed, making double-stranded breaks in two S regions (after they make a switch loop). The ends are joined, DNA is repaired by nonhomologous end-joining (NHEJ), deleting an intervening chromosomal region. One of the constant isotype region is then expressed by the promoter.

52
Q

What is the AID enzyme?

A

Activation Induced Cytosine Deaminase introduces nicks into S DNA region (contain ‘hot spot’ for AID activity, converting C to U bases)

53
Q

Recall the order of the C regions and mention the cytokines that help direct Ig isotype switching.

A
54
Q

Mention the need for CSR.

A

The default isotype is IgM which is pentameric, having 10 Ag binding sites. This greatly increases its avidity, making it suitable for a first, quick response. However, it has a lower affinity compared to other isotypes. In addition, other isotypes may have specialised effector function which is better suited to the specific circumstances.

55
Q

Recall the features and functions of the Ig isotype.

A
56
Q

Recall the 4 mechanisms to generate BCR diversity.

A
57
Q

Mention PIDs affecting B-cell development

A

SCID, XLA/Agammaglobulinaemia

58
Q

Mention examples of Antibody Deficiencies.

A

Hyper-IgM Syndrome, CVID

59
Q

Describe the steps on how B cells solicit help from T cells.

A
  1. Activates B cells gather, process and present antigen to the T cells via the MHC class II
  2. After seeing Ag, activated T cells are co-stimulated (e.g. ICOSL)
  3. Co-stimulated T cells provide ‘help’
    • CD40/CD40L
      • activates NFkB signalling => induces proliferation
      • induces AID-inducing signal
    • Differentiation signal (e.g. IL-4, IL-21)
    • With no help - B cells do nothing
60
Q

Recall the defects in help signalling pathways that lead to PID.

A
61
Q

Describe the different types of Hyper-IgM Syndromes

A
  • XL CD40L deficiency (CD40LG; HIGM1)
    • X-linked, combined immunodeficiency with cellular, humoral, and innate defects
    • defective B cell proliferation, no GCs, no immune memory
  • AR CD40R deficiency (CD40, HIMGM3)
    • humoral immune deficiency, no GC, no immune memory (autosomal recessive)
  • AR/AD-AID deficiency (AICDA, HIGM2, 4)
    • GC can form but no CSR, no switched memory, no SHM (autosomal recessive)
    • If AID-Cterm mutation, similar but SHM normal - autosomal dominant
  • UNG deficiency (UNG, HIGM 5)
    • Acts downstream of AID, GC form, no CSR, no SHM (autosomal recessive)
62
Q

Describe the pathogenesis of the HIGM Syndromes.

A
  • CSR defects
    • signalling or enzymatic defects that block Igμ H chain replacement by other downstream H chain isotypes - T cell defects
  • SHM defects
    • blocks in signalling or enzymatic effectors that prevent introduction of mutations in V region of actively transcribed Ig genes, lack of high-affinity Abs; T cell defects
  • Defect in CD40-CD40L interaction between B and T cell
    • prevent activation of B cell by T cell help; lack of antibodies
63
Q

Mention the symptoms of HIGM Syndromes.

A
  • usually present in first or second year of life
  • recurrent pus-producing (Pyogenic) bacterial infections of upper and lower respiratory tract
  • decreased IgG, normal/abnormally high levels of IgM
  • Variable symptoms and severity of disease
64
Q

How is HIGM Syndrome diagnosed?

A
  • clinical presentation + family history + Ig serum testing (if>6 months)
  • Lymphocyte counts (are T cells present? is it SCID? are B cells present? XLA?)
  • Genetics (CVS pre-natal screening)
  • 70% cases are X-linked (CD40LG)
65
Q

Mention the susceptibilities of HIGM Syndrome.

A
66
Q

Describe the management and therapy of HIGH syndromes.

A
67
Q

_________________ is the largest class of Primary Antibody Deficiency.

A

CVID

68
Q

Describe CVID.

A
69
Q

Recall the effector functions of the Human Ig.

A
70
Q

Recall the overview of the VDJ recombination process

A
71
Q

Recall the major genetic causes of SCID.

A
72
Q

Recall the final checkpoints of immature B cells before release from bone marrow.

A